Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 205

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Randomised controlled trial of long-term maintenance corticosteroid therapy in patients with autoimmune pancreatitis

Masamune, Atsushi, Nishimori, Isao, Kikuta, Kazuhiro, Tsuji, Ichiro, Mizuno, Nobumasa, Iiyama, Tatsuo, Kanno, Atsushi, Tachibana, Yuichi, Ito, Tetsuhide, Kamisawa, Terumi, Uchida, Kazushige, Hamano, Hideaki, Yasuda, Hiroaki, Sakagami, Junichi, Mitoro, Akira, Taguchi, Masashi, Kihara, Yasuyuki, Sugimoto, Hiroyuki, Hirooka, Yoshiki, Yamamoto, Satoshi, Inui, Kazuo, Inatomi, Osamu, Andoh, Akira, Nakahara, Kazuyuki, Miyakawa, Hiroyuki, Hamada, Shin, Kawa, Shigeyuki, Okazaki, Kazuichi, Shimosegawa, Tooru · 2017 · Gut

Abstract

Objective: Corticosteroid has been established as the standard therapy for autoimmune pancreatitis (AIP), but the requirement for maintenance corticosteroid therapy is controversial. We conducted a randomised controlled trial to clarify the efficacy of maintenance corticosteroid therapy in patients with AIP. Design: We conducted a multicentre, tertiary setting, randomised controlled trial. After the induction of remission with the initial oral prednisolone (PSL) treatment, maintenance therapy with PSL at 5–7.5 mg/day was continued for 3 years or withdrawn at 26 weeks. The primary endpoint was relapse-free survival over 3 years and the secondary endpoint was serious corticosteroid-related complications. All analyses were performed on an intention-to-treat basis. Results: Between April 2009 and March 2012, 49 patients with AIP were randomly assigned to the maintenance therapy group (n=30) or the cessation group (n=19). Baseline characteristics were not different between the two groups. Relapses occurred within 3 years in 11 out of 19 (57.9%) patients assigned to the cessation group, and in 7 of 30 (23.3%) patients in the maintenance therapy group. The relapse rate over 3 years was significantly lower in the maintenance therapy group than that in the cessation group (p=0.011). The relapse-free survival was significantly longer in the maintenance therapy group than that in the cessation group (p=0.007). No serious corticosteroid-related complications requiring discontinuation of PSL were observed. Conclusions: Maintenance corticosteroid therapy for 3 years may decrease relapses in patients with AIP compared with those who discontinued the therapy at 26 weeks. Trial registration number: UMIN000001818; Results.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1136/gutjnl-2016-312049

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Cited by

See all 205

Metadata

Authors
Masamune, A., Nishimori, I., Kikuta, K., Tsuji, I., Mizuno, N., Iiyama, T., Kanno, A., Tachibana, Y., Ito, T., Kamisawa, T., Uchida, K., Hamano, H., Yasuda, H., Sakagami, J., Mitoro, A., Taguchi, M., Kihara, Y., Sugimoto, H., Hirooka, Y., Yamamoto, S., Inui, K., Inatomi, O., Andoh, A., Nakahara, K., Miyakawa, H., Hamada, S., Kawa, S., Okazaki, K., & Shimosegawa, T.
Venue
Gut
Publisher
BMJ
Published
2016-08-19
Volume
66
Issue
3
Pages
487-494
ISSN
  • 0017-5749 (ISSN-L)
  • 1468-3288
OpenAlex
W2518504487
Cited by
205
References
1
FWCI
20.47
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Randomised controlled trial of long-term maintenance corticosteroid therapy in patients with autoimmune pancreatitis. https://app.cochat.ai/papers/10.1136/gutjnl-2016-312049
The paper
Masamune, A., Nishimori, I., Kikuta, K., Tsuji, I., Mizuno, N., Iiyama, T., Kanno, A., Tachibana, Y., Ito, T., Kamisawa, T., Uchida, K., Hamano, H., Yasuda, H., Sakagami, J., Mitoro, A., Taguchi, M., Kihara, Y., Sugimoto, H., Hirooka, Y., . . . Shimosegawa, T. (2017). Randomised controlled trial of long-term maintenance corticosteroid therapy in patients with autoimmune pancreatitis. Gut. https://doi.org/10.1136/gutjnl-2016-312049

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.